| Teaminvest Private Group Limited (TIP) ORDINARY FULLY PAID |
Financials |
$32 |
Update - Notification of buy-back - TIP
|
27 May 2025 8:27AM |
$1.750 |
$1.200 |
fallen by
31.43%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$18 |
FY25 Corporate Governance Statement and Appendix 4G
|
27 May 2025 8:26AM |
$0.460 |
$0.285 |
fallen by
38.04%
|
|
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,333 |
Proposed issue of securities - ALQ
|
27 May 2025 8:26AM |
$17.640 |
$22.330 |
risen by
26.59%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$18 |
FY25 Annual Results Investor Presentation
|
27 May 2025 8:26AM |
$0.460 |
$0.285 |
fallen by
38.04%
|
|
STG - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue of NZD $57.2 million with strong gross margins and positive operating cash flow.
- Operating costs reduced by NZD $3.2 million, improving profitability.
- Stable recurring revenue base with enterprise accounts comprising 69% of revenues.
- Expansion of proprietary AI-powered translation platform and technology roadmap.
- Continued growth and penetration in the US market, including new key account wins.
- Cash balance of NZD $21.5 million and no debt as of March 31, 2024.
- Active focus on efficient operations, cost control, and cash generation.
- Investment in scalable technologies, workflow automation, and language AI tools.
- Commitment to responsible use of generative AI and privacy compliance.
- Positive outlook for FY26 with continued focus on profitability, innovation, and shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diversified United Investment Limited (DUI) ORDINARY FULLY PAID |
Financials |
$1,089 |
Weekly NTA - 23 May 2025
|
27 May 2025 8:25AM |
$5.340 |
$5.070 |
fallen by
5.06%
|
|
| New Hope Corporation Limited (NHC) ORDINARY FULLY PAID |
Energy |
$4,556 |
Update - Notification of buy-back - NHC
|
27 May 2025 8:25AM |
$3.720 |
$5.400 |
risen by
45.16%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$293 |
Update - Notification of buy-back - SVR
|
27 May 2025 8:25AM |
$1.660 |
$1.550 |
fallen by
6.63%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,499 |
Update - Notification of buy-back - WHC
|
27 May 2025 8:25AM |
$5.470 |
$7.880 |
risen by
44.06%
|
|
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,333 |
ALS Equity Raise Investor Presentation
|
27 May 2025 8:25AM |
$17.640 |
$22.330 |
risen by
26.59%
|
|
ALQ - Price-sensitive ASX Announcement
Full Release
Key Points
- ALS Limited (ASX: ALQ) is undertaking a fully underwritten equity raise to strengthen its balance sheet and fund future growth initiatives.
- ALS Limited is seeking to raise approximately A$267 million via an institutional placement and a share purchase plan offered to eligible shareholders.
- The proceeds from the equity raise will be used to pay down existing debt, provide balance sheet flexibility, and support future organic and inorganic growth opportunities.
- ALS has a leading global market position in testing, inspection, certification, and verification services, operating across life sciences, commodities, and industrial sectors.
- ALS has performed resiliently through the COVID-19 pandemic, with a diverse and geographically spread revenue base and a focus on mission-critical services.
- The company has a strong strategic focus on expanding its Life Sciences business, which includes environmental, food, pharmaceutical, and consumer product testing.
- ALS's outlook is underpinned by long-term secular trends in regulatory compliance, health & safety, and sustainability.
- The company outlines a disciplined approach to capital allocation, targeting high-return investments, bolt-on acquisitions, and continued focus on operational efficiency.
- ALS highlights its proven track record of successful acquisitions and integration, supporting its growth strategy.
- The investor presentation includes financial summaries, recent performance highlights, details of the equity raise, use of proceeds, and an update on strategic priorities and market positioning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,333 |
Dividend/Distribution - ALQ
|
27 May 2025 8:25AM |
$17.640 |
$22.330 |
risen by
26.59%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$9,721 |
Update - Notification of buy-back - ORI
|
27 May 2025 8:25AM |
$18.640 |
$20.980 |
risen by
12.55%
|
|
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,333 |
Full Year Results Investor Presentation
|
27 May 2025 8:25AM |
$17.640 |
$22.330 |
risen by
26.59%
|
|
ALQ - Price-sensitive ASX Announcement
Full Release
Key Points
- ALS Limited delivered revenue growth and increased underlying earnings for the year ended 31 March 2023.
- Strong performance in Life Sciences and Commodities divisions contributed to positive results.
- Macroeconomic challenges such as inflation and FX volatility were mitigated by operational efficiencies and pricing actions.
- Strategic priorities include further international expansion, technology investment, and sustainability initiatives.
- Ongoing investment in digital solutions and automation across service lines.
- ALS maintained robust cash flow and a strong balance sheet, supporting continued growth.
- The outlook for FY24 is positive with a healthy pipeline and demand for testing services across key sectors.
- The company is committed to delivering long-term shareholder value through disciplined capital allocation and strategic investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$67 |
Update - Notification of buy-back - M7T
|
27 May 2025 8:25AM |
$0.385 |
$0.285 |
fallen by
25.97%
|
|
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$228 |
Update - Notification of buy-back - CDM
|
27 May 2025 8:25AM |
$0.620 |
$0.765 |
risen by
23.39%
|
|
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$34 |
Update - Notification of buy-back - CDO
|
27 May 2025 8:25AM |
$1.595 |
$2.150 |
risen by
34.80%
|
|
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$18 |
FY25 Annual Report
|
27 May 2025 8:25AM |
$0.460 |
$0.285 |
fallen by
38.04%
|
|
| Adelong Gold Limited (ADG) ORDINARY FULLY PAID |
Materials |
$16 |
GDM: GDM commences operations at the Challenger Gold Mine
|
27 May 2025 8:24AM |
$0.008 |
$0.006 |
fallen by
25%
|
|
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$25 |
GDM commences operations at the Challenger Gold Mine
|
27 May 2025 8:24AM |
$0.440 |
$0.370 |
fallen by
15.91%
|
|
| ALS Limited (ALQ) ORDINARY FULLY PAID |
Industrials |
$11,333 |
ALS Full Year Results and Equity Raising
|
27 May 2025 8:24AM |
$17.640 |
$22.330 |
risen by
26.59%
|
|
ALQ - Price-sensitive ASX Announcement
Full Release
Key Points
- ALS Limited reported group revenue growth of 2.8% to $2.38 billion for FY24.
- Underlying NPAT rose to $273 million, a 0.6% increase from the prior year.
- Strong Geochemistry and Asset Care segments compensated for weaker Life Sciences performance.
- Final dividend of 18.6c per share declared, with a full-year total of 35.9c per share.
- ALS announced a $285 million fully underwritten equity raising to fund acquisitions and growth.
- The company's strategy emphasizes portfolio diversification and operational efficiency.
- ALS is investing in technology, innovation, and expanding its global network.
- Market conditions remain supportive in core segments despite challenges in Life Sciences.
- The equity raise will strengthen the balance sheet and provide flexibility for future opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$5,748 |
Bell Potter Emerging Leaders Conference 2025 presentation
|
27 May 2025 8:24AM |
$7.450 |
$8.310 |
risen by
11.54%
|
|
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$34 |
Re-assaying confirms copper-lead-zinc potential at Minbrie
|
27 May 2025 8:24AM |
$0.005 |
$0.013 |
risen by
160%
|
|
LML - Price-sensitive ASX Announcement
Full Release
Key Points
- Re-assaying at Minbrie confirms significant copper, lead, and zinc mineralisation.
- The program aimed to validate historical drill data and improve resource understanding.
- Results show substantial grades of base metals at the prospect.
- Minbrie is validated as a promising exploration target for Lincoln Minerals Limited.
- Next steps include further drilling and geological evaluations to expand resource definition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$18 |
FY25 Annual Results Market Release
|
27 May 2025 8:24AM |
$0.460 |
$0.285 |
fallen by
38.04%
|
|
STG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth and improved profitability in FY25 results.
- Successful integration of AI and proprietary RAY platform across translation services.
- Expansion of enterprise customer base and long-term contract wins with global brands.
- Increase in gross margin due to enhanced operational efficiency.
- Recurring revenue streams continue to grow, providing financial stability.
- Continued investments in technology and innovation to drive future competitiveness.
- Emphasis on cost control and improved cash generation throughout the year.
- Positive outlook for FY25 with expectations for further increases in revenue and earnings.
- Leadership in AI-driven translation positioned Straker as a key industry player.
- Maintained strong financial discipline while scaling operations globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Straker Limited (STG) ORDINARY FULLY PAID |
Industrials |
$18 |
FY25 Appendix 4E
|
27 May 2025 8:24AM |
$0.460 |
$0.285 |
fallen by
38.04%
|
|
STG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for FY24 was $54.8 million, down 3% from the prior year.
- Loss of a major enterprise client and weaker global demand impacted results.
- Operating EBITDA was $4.6 million, reflecting disciplined cost management.
- Net loss after tax was $2.4 million, improving from $3.4 million loss in FY23.
- Operating cash flow remained positive at $6.2 million.
- Continued investment in the RAY AI-powered translation platform.
- Partnership expansion with global technology companies, notably IBM.
- Focus on delivering scalable, AI-driven language solutions for clients.
- Cost optimization measures reduced overheads and improved gross margins.
- The balance sheet remains strong, with $13.1 million in cash and no debt.
- Board commentary emphasizes market opportunity and technology leadership.
- No final dividend declared for FY24.
- Management outlook is cautiously optimistic, prioritizing growth and profitability.
- Appendix 4E includes audited financial statements and compliance disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,758 |
Update - Notification of buy-back - ORA
|
27 May 2025 8:24AM |
$1.925 |
$1.435 |
fallen by
25.45%
|
|
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,451 |
Appendix 3 Y J Fowles
|
27 May 2025 8:23AM |
$1.635 |
$2.040 |
risen by
24.77%
|
|
Call 1300 880 160
Start a chat
Schedule a call
